241 filings
8-K
DBVT
DBV Technologies
7 May 24
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
4:39pm
8-K
DBVT
DBV Technologies
8 Mar 24
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
4:05pm
8-K
DBVT
DBV Technologies
7 Mar 24
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
5:17pm
8-K
DBVT
DBV Technologies
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:05am
8-K
DBVT
DBV Technologies
9 Nov 23
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
4:52pm
8-K/A
v5wok5w9
6 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K/A
k4d908
2 Nov 23
Departure of Directors or Certain Officers
8:00am
8-K
htzmbw4jvqo8r6ou
31 Oct 23
Termination of a Material Definitive Agreement
4:54pm
8-K
88j6i4 024dnp5nfl3
16 Oct 23
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
4:28pm
8-K
yo4i 7dlg5qibmftb0mt
31 Jul 23
Results of Operations and Financial Condition
5:20pm
8-K
rk15j0b zd
11 May 23
DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
8:27am
8-K
gbmb6xci
4 May 23
DBV Technologies Reports First Quarter 2023 Financial Results
4:43pm
8-K
w243zo86blm2 z6z
19 Apr 23
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA
8:47pm
8-K
7dkd4aw01gi5dhy
13 Apr 23
Submission of Matters to a Vote of Security Holders
8:01am
8-K
f48ueo1xsb2txlme 7y
10 Mar 23
Regulation FD Disclosure
5:59pm
8-K
i13 k8ud9t
7 Mar 23
DBV Technologies Announces First Patient
5:09pm
8-K
vfcwi
2 Mar 23
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
6:29pm
8-K
348nj5jl
23 Dec 22
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
9:59am
8-K
xq69p dtz9jd
3 Nov 22
DBV Technologies Reports Third Quarter Financial Results and Business Update
5:18pm
8-K
zz8688m1ol81 o5d3g
4 Oct 22
DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors
7:32am